Are you not Long TROV?
I Assumed you Were?
Did you Change you Sentiment on it?
I feel TROV is getting Stronger and Looking Better with this New CEO and team, besides the pps not Exploding yet! But that always Follows Later... Give it a Little Time my Friend! This Co has been thought the Trenches and Back!
$12 New Price Target is Bullish and the News Recently was Excellent!
About the University of Michigan Comprehensive Cancer Center
The University of Michigan Cancer Center is one of only 45 centers in the United States to earn the National Cancer Institute's "comprehensive" designation. This, the highest designation in the understanding and treatment of cancer, confirms our commitment to outstanding clinical care, wide-ranging research initiatives, education, outreach and the training of tomorrow's cancer experts. The Cancer Center is also a founding member of the National Comprehensive Cancer Network, a consortium of 27 of the nation's premier centers, which develops national guidelines for the delivery of effective, quality care. Among more than 900 hospitals considered, the University of Michigan ranks 28th on the U.S. News list of best hospitals for cancer - Michigan is the only hospital in the state to rank in the top 50.
Trovagene and University of Michigan Enter into Collaboration for Monitoring and Early Detection of Pancreatic Cancer
Trovagene's KRAS ctDNA liquid biopsy test will be at the forefront of research partnership with Dr. Diane Simeone at University of Michigan Health System
I just Post What I Find!
No Need to Thank Me!
Most of us Know what a Gem this is Going to Be!
Just Takes Time to Make it into a Diamond...
Inst are Building Positions in TROV!
They Know it's Inexpensive for what the Future Brings in this Sector!
Tons of Cash!
Geode Capital Management LLC Buys 2,363 Shares of TrovaGene Inc (TROV)
July 1st, 2016 - 0 comments - Filed Under - by Mark Dietrich
TrovaGene logoGeode Capital Management LLC increased its stake in TrovaGene Inc (NASDAQ:TROV) by 1.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 183,442 shares of the company’s stock after buying an additional 2,363 shares during the period. Geode Capital Management LLC owned 0.62% of TrovaGene worth $853,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of TROV. State Street Corp raised its position in TrovaGene by 21.3% in the first quarter. State Street Corp now owns 390,759 shares of the company’s stock valued at $1,819,000 after buying an additional 68,557 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its position in TrovaGene by 6.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 660,640 shares of the company’s stock valued at $3,072,000 after buying an additional 40,100 shares in the last quarter. Prospera Financial Services Inc raised its position in TrovaGene by 3.8% in the first quarter. Prospera Financial Services Inc now owns 158,125 shares of the company’s stock valued at $735,000 after buying an additional 5,800 shares in the last quarter. Finally, First Eagle Investment Management LLC bought a new position in TrovaGene during the fourth quarter valued at about $2,031,000.
I'm Sure Many are on the Way!
This will be a Slow Crawl Climb Up!
But, does it Deserve to be Under $10?